ArticleDigestive diseases and sciences2026
Endoscopy Unit Implementation of a Sealed In-Room Air Purifier with Ultraviolet Irradiation Reduces Bacterial and Airborne Particle Levels.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThere is a need for enhanced air quality in healthcare settings, particularly in areas with high levels of airborne particles and complex room layouts. This study evaluated the impact of germicidal ultraviolet air purification devices (GUVAPD) on bacterial contamination and airborne particle levels in endoscopic procedural rooms.
methodsWe compared two endoscopy rooms and assessed whether GUVAPDs would further improve air quality above standard cleaning protocols. We compared an experimental room equipped with four germicidal ultraviolet chambers (Clean Air Unit, UV Angel) and a control room; both rooms performed similar endoscopic procedures. Microbial air and settled surface samples were collected, and airborne particle counts (0.3 and 2.5 um) were performed before and after the installation of GUVAPD, using standard techniques.
resultsA significant 79% reduction of airborne bacterial colony-forming units (CFUs) from 130.8 to 27.2 CFUs (p < 0.0001) and a 68% reduction in settled surface bacterial CFUs from 10.2 to 5.7 CFUs (p = 0.016) were observed following installation of GUVPADs. Additionally, particulate matter measurements indicated a particle reduction of 47% and 75% (0.3 and 2.5 micron, respectively) after installation of GUVAPDs.
conclusionsThese findings demonstrate that supplemental UV air treatment administered via GUVAPD effectively reduced both microbial and particulate contaminants in a complex room environment. Integrating GUVAPDs into current infection control strategies holds promising potential for improving patient and staff safety. Future research should explore the long-term effects and applicability of these systems in diverse clinical settings to further establish their efficacy in mitigating infections.
Indexed as
Identifiers
40993303What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.